Pradžia › Ewingo sarkoma › Florida
Ewingo sarkoma klinikiniai tyrimai Florida
7 tyrimai dėl Ewingo sarkoma ieško dalyvių vietose Florida.
Miestai Florida
Oficialus tyrimo tekstas (anglų kalba)
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- University of Florida, Gainesville
- Nemours Jacksonville, Jacksonville
- University of Miami, Miami
- ir dar 2
Renkami dalyviai1 fazė
Amžius 1 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07194044Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Johns Hopkins All Children's Hospital ( Site 1025), St. Petersburg
Renkami dalyviai1/2 fazė
6 Months – 25 Years · Visoms lytims · Atnaujinta 2026-09-17 · NCT06395103Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- ir dar 1
Renkami dalyviai1/2 fazė
Iki 26 metų · Visoms lytims · Atnaujinta 2026-09-03 · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- ir dar 2
Renkami dalyviai1/2 fazė
Iki 30 metų · Visoms lytims · Atnaujinta 2026-09-03 · NCT06541262Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- St. Joseph's Children's Hospital, Tampa
Renkami dalyviai2 fazė
Amžius nuo 0 iki 50 · Visoms lytims · Atnaujinta 2026-07-09 · NCT07321912Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
- University of Florida, Gainesville
Renkami dalyviai1/2 fazė
6 Months – 25 Years · Visoms lytims · Atnaujinta 2026-06-30 · NCT06625190Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Johns Hopkins All Children's Hospital, St. Petersburg
Renkami dalyviai1/2 fazė
Amžius nuo 2 iki 30 · Visoms lytims · Atnaujinta 2026-02-03 · NCT05734066Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.